Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia...

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Copper, zinc-superoxide dismutase (Cu,Zn-SOD) is crucial for cellular defense against oxidative stress.
• Erythrocyte Cu,Zn-SOD activity is implicated in various diseases, including diabetes mellitus (DM).
• Understanding Cu,Zn-SOD's role in Type 2 DM pathogenesis is vital for metabolic disease research.

Purpose of the Study:

• To investigate alterations in erythrocyte Cu,Zn-SOD activity and concentration in Type 2 DM patients.
• To compare these changes with indicators of glycemic control, such as HbA1c and fasting blood glucose.
• To elucidate the relationship between hyperglycemia, Cu,Zn-SOD inactivation, and erythrocyte enzyme levels.

Main Methods:

• Quantification of Cu,Zn-SOD enzymatic activity in erythrocytes.
• Measurement of Cu,Zn-SOD protein concentration in erythrocytes.
• Correlation analysis with clinical parameters: HbA1c, fasting blood glucose, plasma cholesterol, and triglycerides.

Main Results:

• Erythrocyte Cu,Zn-SOD activity was significantly reduced in Type 2 DM patients compared to healthy controls.
• Enzyme activity showed a negative correlation with HbA1c levels.
• No significant difference in erythrocyte Cu,Zn-SOD concentration was observed between diabetic and control groups, nor did it correlate with activity or HbA1c.

Conclusions:

• The findings suggest that hyperglycemia in Type 2 DM leads to the inactivation of erythrocyte Cu,Zn-SOD, rather than a decrease in its concentration.
• Glycosylation of the enzyme's active site is a potential mechanism for this inactivation.
• These results highlight a specific molecular consequence of chronic hyperglycemia on antioxidant defense in red blood cells.